Your browser doesn't support javascript.
loading
Evaluation of selective screening of donors for antibody to Trypanosoma cruzi: seroprevalence of donors who answer "no" to risk questions.
O'Brien, Sheila F; Scalia, Vito; Goldman, Mindy; Fan, Wenli; Yi, Qi-Long; Huang, Mary; Ndao, Momar; Fearon, Margaret A.
Afiliación
  • O'Brien SF; Canadian Blood Services, Ottawa, Ontario, Canada; Department of Epidemiology & Community Medicine, Department of Pathology & Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Pathology & Laboratory Medicine, University of Toronto, Toronto, Ontario, Canada; National Reference Center for Parasitology, McGill University, Montreal, Quebec, Canada.
Transfusion ; 54(3 Pt 2): 863-9, 2014 Mar.
Article en En | MEDLINE | ID: mdl-23614476
BACKGROUND: Selective testing of donors for Trypanosoma cruzi infection relies on identification of at-risk donors with screening questions. Using risk modeling and a seroprevalence study, we evaluated the risk of questions failing to identify T. cruzi antibody-positive donors. STUDY DESIGN AND METHODS: The rate of donors with unreported risk was estimated by a telephone survey of 2677 donors who answered "no" to risk questions. The number of T. cruzi antibody-positive donors missed by risk questions was estimated from the product of this rate and the selective testing T. cruzi antibody-positive rate. The 95% confidence interval (CI) was estimated by Monte Carlo simulation. To test the model, 60,132 donors were tested for T. cruzi antibody (26% of donors in selected regions, Phase I). In Winnipeg, Manitoba, the highest-risk region, 26,915 donors were tested (92.5% of donors, Phase II). RESULTS: In the telephone survey, 21 (0.8%) donors reported risk factors that would have identified them for selective testing. Seven were born in Mexico or Central or South America, five had travel risk, and nine had mother or maternal grandmother risk. The 95% CI for predicted number of T. cruzi antibody-positive donors answering "no" to risk questions was 0.71 to 4.38. In Phase I, one Winnipeg donor confirmed positive but had answered risk questions correctly. No other positive donations were identified. CONCLUSION: The estimated risk of T. cruzi-positive donors who answer "no" to risk questions is low and is confirmed by the seroprevalence among these donors.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trypanosoma cruzi / Anticuerpos Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Transfusion Año: 2014 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trypanosoma cruzi / Anticuerpos Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Transfusion Año: 2014 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos